. Author manuscript; available in PMC: 2022 Mar 1.

Published in final edited form as: Int J Tuberc Lung Dis. 2021 Mar 1;25(3):167–170. doi: 10.5588/ijtld.20.0830

Table 2.

Opportunities for innovation in TB-COVID-19 research and clinical care

Research phase	Opportunities
Design	Integrate research into COVID-19 response
	Community input on optimal responses to TB research and care via community advisory boards
	Expedited ethics review of minimal risk study designs, such as retrospective studies
	Mobile technology to enhance recruitment and retention
Implementation	TB and COVID-19 screening/contact tracing
	Combined TB-COVID-19 surveillance systems
	Remote clinical or research visits (VOT)
	Utilizing existing testing platforms and human resources to scale up SARS-CoV-2 testing (i.e., GeneXpert; Cepheid, Sunnyvale, CA, USA)
	Maintaining adaptable research programs

COVID-19 = coronavirus disease 2019; VOT = video-observed therapy; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.